PharmedOut is a project at Georgetown that advances evidence-based prescribing and educates about pharmaceutical and medical device marketing practices.
📢New article on vaginal estrogen and the prevention of recurrent UTIs in postmenopausal women from PharmedOut's Patricia Bencivenga, Dr. Adriane Fugh-Berman, and Dr. Tony Scialli. Read it here: fertstertreviews.org/article…
đź”´ In F&S Reviews:
Vaginal estrogen and the prevention of recurrent urinary tract infection in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials
Full text 👇
fertstertreviews.org/article…
"We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850." @statnews First Opinion article outlining how "open-access journal fees pose barriers to making NIH-funded research available to the public."
statnews.com/2026/06/11/open…
American Diabetes Association throws researchers under the bus for defending science: Police Remove Diabetes Experts From Conference for Distributing Critique of Trump Administration nytimes.com/2026/06/05/well/… via @NYTimes
To sign petition supporting scientists removed from ADA meeting for distributing article criticizing Trump administration science policies: change.org/p/an-open-letter-…
You can also read their accompanying STAT article on the issue, "The perimenopause movement sells women the lie that they are ruled by their hormones" here: statnews.com/2026/03/26/peri…
Kenny Lin: New ACC/AHA statin guidelines failed to do systematic review, didn't include national internal medicine and family medicine organizations, and 12/33 on guideline panel had relevant conflicts of interest. medscape.com/viewarticle/gra…
Recent turbulence at the @US_FDA shows why PharmedOut's aptly named report "What Needs to Change at the FDA?" is especially relevant today!
Read the executive summary and the report here: sites.google.com/georgetown.…
ALT PharmedOut's report on the FDA examines four main themes including transparency and accountability, innovation, pre- and post-market standards of evidence, and value in healthcare.
Jeanne Lenzer's great article on tests that make perfectly healthy people think they have Alzheimer’s. Fugh-Berman is quoted saying “These are bad tests designed to make people eligible for bad drugs.” levernews.com/the-campaign-t…
So let me get this straight…
What’s in: tanning beds, flavored vapes
What’s out: vaccines, anti-depressants
RFK Jr. clears path for minors' use of tanning beds, much to the dismay of dermatologists latimes.com/science/story/20…
As the Sackler family worked through a plan to pay $6.5 billion to resolve their liability over Purdue Pharma’s production of addictive opioids, the epidemic hit even closer to home. bloomberg.com/news/articles/…
"Opioid manufacturers unethically changed what prescribers thought they knew about opioids, and changed how chronic pain was treated." Read more here: cambridge.org/core/journals/…
ALT New publication from PharmedOut titled Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use.
"Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use" reveals the origins and impact of terms such as opiophobia and pseudoaddiction. Pharma influence on knowledge about drugs is a serious concern.
tinyurl.com/rzvh4k72